January 2017

Letter from the Editor

January 1, 2017

Welcome to 2017 From funding to policy changes, 2017 according to analysts will be marked by uncertainty and opportunity. As the industy, as well as the country, prepares for the Trump Administration, EY U.S. Analyst Arda Ural, Ph.D., details the impact the new president’s policies will have on drug pricing, regulation, parallel importation, taxes, M&A […]

Upfront

January 1, 2017

Lilly to Expand  Global Access to Healthcare Eli Lilly and Company has launched an ambitious plan to increase access to healthcare and to improve long-term health for millions of people worldwide. Through investments in people, medicines and health systems, Lilly aims to reach 30 million people in resource-limited settings annually by 2030. Working with expert […]

A Conversation with Dr. Cameron Durrant

January 1, 2017

In an exclusive interview with PharmaVOICE’s Editor Taren Grom, Cameron Durrant, M.D., current CEO and chairman of KaloBios, talks about taking the helm of the embattled small biotech company amid controversy, bankruptcy, and uncertainty, as well as the personal lessons learned along the way as he rights the ship. KaloBios, which is dedicated to advancing […]

Innovator’s Corner

January 1, 2017

A New Way to Treat Severe Asthma Dr. Bing Yao, Respiratory, Inflammation & Autoimmunity Head at MedImmune, talks about the company’s efforts to develop a next-generation asthma therapy. Severe, uncontrolled asthma is a debilitating and potentially fatal form of the disease. Uncontrolled asthma can lead to a dependence on oral corticosteroids, which have serious and […]

HealthTech

January 1, 2017

AI and mHealth Tech: Instruments to Better Healthcare Computers can be trained to be more accurate than pathologists in assessing slides of lung cancer tissues, according to a study by researchers at the Stanford University School of Medicine. The researchers found that a machine-learning approach to identifying critical disease-related features accurately differentiated between two types […]

Last Word

January 1, 2017

Rising Pharma Opportunities in China Rick Pauls, President and CEO of DiaMedica, talks about how the Chinese market is poised for growth. PV: Why do you think the Chinese market has potential for the pharmaceutical industry? Pauls: The westernization of China is leading to increases in many diseases, such as stroke and kidney diseases. Much […]

Venture Capital Funding

January 1, 2017

According  to the MoneyTree Report from PwC, the life-sciences industry continues to be the second most invested destination after software, in terms of dollars. Life-Sciences’ VC Investment The life-sciences’ record-high investment spree of 2015 came to an end in Q4 with the lowest quarter of investments during the year, signaling a slow down in the […]

Don’t Mistake Copy for Content Marketing

January 1, 2017

More than half — 58% — of the pharma/biotech industry is spending more than $50 million in content development every year, but much of that content is not connected to a solid objective, which means money and time are being wasted. In a recent Accenture study, only 11% of pharma/biotech marketers reported they have a […]

Organs On Chips

January 1, 2017

One day, precision medicine will take into account the genes, environment, and lifestyle of each person. Through the use of an emerging technology that melds engineering, biology, and IT, researchers are able to see what hasn’t been possible before: the inner workings of human biology and disease. This new technology is just starting to be […]

Global Expedited Review

January 1, 2017

Following the implementation of the Food and Drug Administration’s  Breakthrough Therapy Designation in 2012, both the European Union’s and Japan’s regulatory agencies began the process of determining how to provide an expedited review for therapies for serious diseases with unmet needs. The results of these efforts included the European Medicines Agency’s launch of the PRIME […]

Disease State: HIV Update

January 1, 2017

Since the beginning of the HIV epidemic, almost 70 million people worldwide have been infected with the virus that causes AIDS. It is estimated that 36.7 million people are currently living with HIV globally. Tremendous gains have been made in treating these patients, helping them to live longer, healthier lives. Antiretroviral drugs have been credited […]

Focus on Rare Diseases

January 1, 2017

Rare diseases have been a focus of drug development for decades, and since the 1980s, there have been financial, legal, and legislative incentives, such as the Orphan Drug Act, that are drawing companies of all sizes to enter the market. Rafal Kokolus, senior engagement manager, inVentiv Health Consulting, believes the rare disease market has passed […]

SHOWCASE FEATURE: Social Media

January 1, 2017

Social Media Trends What’s hot, what’s not, and the analytics driving it all. For the first time, digital and social media ad spending — $72.09 billion — surpassed that of TV — $71.29 billion, according to a recent study from eMarketer. This shift may have marketers everywhere revisiting their strategies, leading to big changes in […]

Social Media Is Pharma’s Key To Reaching Millennials

January 1, 2017

Millennials? Hmmph. “I’m sick of hearing about them. They’re not driving my business, and I couldn’t care less about them.” If you fall into this camp, you’re not reading the tea leaves. Today, the average age of a millennial is 26. They are the largest generation in the United States, at 75.4 million people,1 and […]

Ease Your Way Into Social

January 1, 2017

As the generation marketers have labeled “millennials” mature into their role as heads of family and healthcare consumers, how can modern pharmaceutical brands begin to build a relationship with them? For a generation that has come of age as digital and social media natives, how do we engage with millennials in their most comfortable zone? […]

Transcending Traditional Social Media: From Awareness to Uncovering Actionable Insights

January 1, 2017

It goes without saying that social media is one of the most widely used forms of communication today.  Pharmaceutical companies are trying to “crack the code” and understand how to effectively use this channel to achieve organizational initiatives while complying with rigorous industry regulations. Progressive companies have navigated this challenging environment, breaking new ground and […]

FEEDBACK